Evaluation of Aspartate aminotransferase (AST) to platelet Ratio Index (ApRI) test as noninvasive fibrosis biomarker in HCV and shistosomal chronic liver diseases
Fatma Sobhy Ibrahim;
Abstract
The aim of our study was to evaluate recent non invasive fibrosis biomarker test (ApRI test) in the diagnosis of the stage of hepatic fibrosis as compared to liver biopsy as a golden standerd.
The study included 50 patients (20 patients with HCV related
The study included 50 patients (20 patients with HCV related
Other data
| Title | Evaluation of Aspartate aminotransferase (AST) to platelet Ratio Index (ApRI) test as noninvasive fibrosis biomarker in HCV and shistosomal chronic liver diseases | Other Titles | تقييم اختبار (ا ب ر ى) كعلامة بيولوجية غير تداخلية للتليّف فى مرضى الكبد الفيروسى (ج) ومرضى الكبد البلهارسى | Authors | Fatma Sobhy Ibrahim | Keywords | Evaluation of Aspartate aminotransferase (AST) to platelet Ratio Index (ApRI) test as noninvasive fibrosis biomarker in HCV and shistosomal chronic liver diseases | Issue Date | 2012 | Description | The aim of our study was to evaluate recent non invasive fibrosis biomarker test (ApRI test) in the diagnosis of the stage of hepatic fibrosis as compared to liver biopsy as a golden standerd. The study included 50 patients (20 patients with HCV related |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 111073p6371.pdf | 370.86 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.